z-logo
open-access-imgOpen Access
Tumor Necrosis Factor Alpha Ototoxicity Is Associated with Upregulation of Smac/Diablo Gene Expression in Rat Organ of Corti Explants
Author(s) -
Dinh Christine Thuyvan,
Dinh John,
Vu Ly,
Yan Denise,
Liu XueZhong,
Van De Water Thomas
Publication year - 2011
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599811416318a199
Subject(s) - organ of corti , tumor necrosis factor alpha , biology , apoptosis , andrology , in vitro , explant culture , gene expression , necrosis , microbiology and biotechnology , immunology , cochlea , gene , anatomy , medicine , genetics
Objective 1) Review the role of tumor necrosis factor alpha (TNFa) in programmed cell death of auditory hair cells (AHCs) in organ of Corti (OC) explants in vitro. 2) Understand effects of TNFa on Smac/Diablo gene expression in TNFa‐induced apoptosis of OC explants in vitro. Method OC explants were dissected from 3‐day‐old rat pups and cultured in (1) no treatment – control and (2) TNFa (2ug/mL) for 96 hours in vitro for hair cell count studies and 24 and 48 hours in vitro for gene expression studies for GAPDH and Smac/Diablo genes. Results There are statistically significant decreases in the numbers of viable inner and outer hair cells in TNFa‐treated OC explants, when compared with the control group. Gene expression of pro‐apoptotic Smac/Diablo is significantly increased at 48 hours in vitro (but not at 24 hours), when compared with controls. On‐going studies are evaluating the expression of Smac/Diablo gene at 72 and 96 hours in vitro. Conclusion The role of Smac/Diablo gene expression has not previously been studied in TNFa‐challenged OC explants. These results suggest late up regulation of Smac/Diablo expression in TNFa ototoxicity, which may be important for the propagation of the apoptosis pathway in OC explants in vitro. (NIDCD RO1‐05575)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here